Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments

Go back to Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments

Avid Bioservices (CDMO) Reports Q2 EPS of $0.06

September 1, 2020 4:14 PM EDT

Avid Bioservices (NASDAQ: CDMO) reported Q2 EPS of $0.06, versus ($0.08) reported last year. Revenue for the quarter came in at $25.4 million, versus $15.3 million reported last year.

GUIDANCE:

Avid Bioservices sees FY2020 revenue of $76-81 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

... More